Results 181 to 190 of about 4,626,170 (385)
Background Tumor recurrence and mortality rates remain challenging in cancer patients despite comprehensive treatment. Neoadjuvant chemotherapy and immunotherapy aim to eliminate residual tumor cells, reducing the risk of recurrence.
Yaoyao Zhou+11 more
doaj +1 more source
Bax to Bcl-2 Ratio and Ki-67 Index are Useful Predictors of Neoadjuvant Chemoradiation Therapy in Bladder Cancer [PDF]
Hiroaki Matsumoto
openalex +1 more source
ABSTRACT Introduction Thyroblastoma is a rare, aggressive thyroid neoplasm newly classified in the 2022 WHO Classification of Endocrine Tumors. It is characterized by embryonal, multilineage morphology and DICER1 mutations. Fewer than 15 well‐characterized cases have been reported, with limited cytological descriptions.
R. Razack+7 more
wiley +1 more source
BackgroundEarly studies have revealed antagonistic effects associated with stacking chemotherapy (CT) and endocrine therapy (ET), thereby conventional wisdom does not advocate the simultaneous combination of these two treatment modalities.
Nengying Zhang+9 more
doaj +1 more source
Primary Lung Cancer Response to Neoadjuvant Therapy Evaluated by CT and MR Images.
Mayumi Seto+8 more
openalex +2 more sources
Neoadjuvant therapy changes the lymphocyte composition of tumor‐draining lymph nodes in cervical carcinoma [PDF]
Andrea Fattorossi+6 more
openalex +1 more source
Bioinformatics analysis of immune‐programmed cell death‐related genes in nasopharyngeal carcinoma
Abstract Background Nasopharyngeal carcinoma (NPC) is a prevalent malignant tumor of the head and neck, characterized by a complex pathogenesis. Most newly diagnosed NPC patients are locally advanced, and 20%–30% of advanced NPC patients have poor immunotherapy results.
Hongqiang Chen+3 more
wiley +1 more source
Prospective evaluation of estrogen receptor-β in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients [PDF]
Vera Cappelletti+12 more
openalex +1 more source